May 9, 2017 09:04 AM EDT
R&D

Re­cro Phar­ma tees up an NDA for its COX-2 pain drug fol­low­ing pos­i­tive PhI­II pro­gram

Arsalan Arif

Founder

Lit­tle, Malvern, PA-based Re­cro Phar­ma $REPH post­ed pos­i­tive Phase III da­ta for the IV for­mu­la­tion of their pain ther­a­py meloxi­cam. Shares bumped up 10 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

A service from the Financial Times